Adelaide Research & Scholarship: Search

Search

Results 1-10 of 11 (Search time: 0.002 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2018	Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation: an ARISTOTLE substudy	Horowitz, J.; De Caterina, R.; Heresztyn, T.; Alexander, J.; Andersson, U.; Lopes, R.; Steg, P.; Hylek, E.; Mohan, P.; Hanna, M.; Jansky, P.; Granger, C.; Wallentin, L.
	2014	High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial	Hijazi, Z.; Siegbahn, A.; Andersson, U.; Granger, C.; Alexander, J.; Atar, D.; Gersh, B.; Mohan, P.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Wallentin, L.
	2014	Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial	Wallentin, L.; Hijazi, Z.; Andersson, U.; Alexander, J.; De Caterina, R.; Hanna, M.; Horowitz, J.; Hylek, E.; Lopes, R.; Åsberg, S.; Granger, C.; Siegbahn, A.
	2016	History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial	De Caterina, R.; Andersson, U.; Alexander, J.; Al-Khatib, S.; Bahit, M.; Goto, S.; Hanna, M.; Held, C.; Hohnloser, S.; Hylek, E.; Lanas, F.; Lopes, R.; López-Sendón, J.; Renda, G.; Horowitz, J.; Granger, C.; Wallentin, L.
	2016	Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation	Hijazi, Z.; Aulin, J.; Andersson, U.; Alexander, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; Lopes, R.; Siegbahn, A.; Wallentin, L.
	2015	Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy	Hijazi, Z.; Siegbahn, A.; Andersson, U.; Lindahl, B.; Granger, C.; Alexander, J.; Atar, D.; Gersh, B.; Hanna, M.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Wallentin, L.
	2010	Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale	Lopes, R.; Alexander, J.; Al-Khatib, S.; Ansell, J.; Diaz, R.; Easton, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; McMurray, J.; Verheugt, F.; Wallentin, L.
	2012	Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial	Lopes, R.; Al-Khatib, S.; Wallentin, L.; Yang, H.; Ansell, J.; Bahit, M.; De Caterina, R.; Dorian, P.; Easton, J.; Erol, C.; Ezekowitz, J.; Gersh, B.; Granger, C.; Hohnloser, S.; Horowitz, J.; Hylek, E.; McMurray, J.; Mohan, P.; Vinereanu, D.; Alexander, J.
	2014	High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin	Hijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Alexander, J.; Atar, D.; Gersh, B.; Hanna, M.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C.
	2014	D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial	Christersson, C.; Wallentin, L.; Andersson, U.; Alexander, J.; Ansell, J.; De Caterina, R.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Huber, K.; Husted, S.; Hylek, E.; Lopes, R.; Siegbahn, A.